Inventor · disambiguated record
Yu Pu
Also filed as: PU YU · PU YU-MING · PU YU-MING M
19 granted patents·10 pending applications·48 citations·filing 2001–2022
92Inventor score
Top patents by PatentIndex Score
29 records- 0193US11129821B2Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2019·Granted Sep 28, 2021·5 cites·26 claims
- 0293US10052315B2Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2017·Granted Aug 21, 2018·11 cites·50 claims
- 0390US10449187B2Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2018·Granted Oct 22, 2019·6 cites·13 claims
- 0485US7153889B2Bicyclic-substituted amines as histamine-3 receptor ligandsABBOTT LAB·Filed 2003·Granted Dec 26, 2006·18 cites·31 claims
- 0578US7662958B2Anti-infective agentsWAGNER ROLF·Filed 2007·Granted Feb 16, 2010·2 cites·2 claims
- 0677US11883389B2Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2021·Granted Jan 30, 2024·0 cites·23 claims
- 0775US9006438B2Processes for the preparation of an apoptosis-inducing agentABBVIE INC·Filed 2014·Granted Apr 14, 2015·1 cites·23 claims
- 0872US10543214B2Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamideCELGENE CORP·Filed 2018·Granted Jan 28, 2020·0 cites·62 claims
- 0971US11701362B2Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1- methylcyclohexane-1-carboxamideCELGENE CORP·Filed 2020·Granted Jul 18, 2023·0 cites·25 claims
- 1069US10898488B2Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamideCELGENE CORP·Filed 2020·Granted Jan 26, 2021·0 cites·33 claims
- 1167US10653697B2Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamideCELGENE CORP·Filed 2019·Granted May 19, 2020·0 cites·39 claims
- 1265US7947711B2Bicyclic-substituted amines as histamine-3 receptor ligandsABBOTT LAB·Filed 2008·Granted May 24, 2011·0 cites·28 claims
- 1363US6710185B2Process for the preparation of cell proliferation inhibitorsABBOTT LAB·Filed 2001·Granted Mar 23, 2004·2 cites·11 claims
- 1461US6822101B2Process for preparing amine-substituted benzofuransABBOTT LAB·Filed 2003·Granted Nov 23, 2004·2 cites·5 claims
- 1559US7145005B22-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparationABBOTT LAB·Filed 2004·Granted Dec 5, 2006·1 cites·4 claims
- 1658US2025368603A1Process of making apoptosis-inducing agentsABBVIE INC·Filed 2022·Application pending·0 cites
- 1753US9199992B2Processes for the preparation of an apoptosis-inducing agentABBVIE INC·Filed 2015·Granted Dec 1, 2015·0 cites·9 claims
- 1853US2020206212A1Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2019·Application pending·0 cites
- 1950US2005054677A1Process for preparing amine-substituted benzofuransFiled 2004·Application pending·0 cites
- 2048US8273767B2Bicyclic-substituted amines as histamine-3 receptor ligandsALTENBACH ROBERT J·Filed 2010·Granted Sep 25, 2012·0 cites·27 claims
- 2148US2019030018A1Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2018·Application pending·0 cites
- 2247US2015065724A1Diastereoselective methods for synthesizing compoundsABBVIE INC·Filed 2014·Application pending·0 cites
- 2344US2023295160A1Salt form and crystal form of jak inhibitor, preparation method therefor, and use thereofSHANGHAI FUDAN ZHANGJIANG BIO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2442US9238652B2Processes for the preparation of an apoptosis-inducing agentABBVIE INC·Filed 2015·Granted Jan 19, 2016·0 cites·23 claims
- 2541US2005256309A1Tri-and bi-cyclic heteroaryl histamine-3 receptor ligandsALTENBACH ROBERT J·Filed 2004·Application pending·0 cites
- 2641US2005256118A1Bicyclic-substituted amines having cyclic-substituted monocyclic substituentsALTENBACH ROBERT J·Filed 2004·Application pending·0 cites
- 2740US2004092521A1Bicyclic-substituted amines as histamine-3 receptor ligandsFiled 2002·Application pending·0 cites
- 2839US2004054185A1Process for preparing amine-substituted benzofuransFiled 2003·Application pending·0 cites
- 2929US8816086B2Process for preparing cannabinoid receptor ligandsPU YU-MING·Filed 2010·Granted Aug 26, 2014·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →